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Retinitis pigmentosa (RP) is a genetically heterogeneous retinal degeneration characterized by photoreceptor death, which results in
visual failure. Here, we used a combination of homozygosity mapping and exome sequencing to identify mutations in ARL2BP, which
encodes an effector protein of the small GTPases ARL2 and ARL3, as causative for autosomal-recessive RP (RP66). In a family affected by
RP and situs inversus, a homozygous, splice-acceptor mutation, c.1011G>C, which alters pre-mRNA splicing of ARLBP2 in blood RNA,
was identified. In another family, a homozygous c.134T>G (p.Met45Arg) mutation was identified. In themouse retina, ARL2BP localized
to the basal body and cilium-associated centriole of photoreceptors and the periciliary extension of the inner segment. Depletion of
ARL2BP caused cilia shortening. Moreover, depletion of ARL2, but not ARL3, caused displacement of ARL2BP from the basal body, sug-
gesting that ARL2 is vital for recruiting or anchoring ARL2BP at the base of the cilium. This hypothesis is supported by the finding that
the p.Met45Arg amino acid substitution reduced binding to ARL2 and caused the loss of ARL2BP localization at the basal body in ciliated
nasal epithelial cells. These data demonstrate a role for ARL2BP and ARL2 in primary cilia function and that this role is essential for
normal photoreceptor maintenance and function.Retinitis pigmentosa (RP [MIM 268000]), the most fre-
quent inherited retinal degeneration, comprises a group
of conditions characterized by the initial loss of rod photo-
receptors and the resulting impaired night vision followed
by progressive visual-field constriction as both rod and
cone photoreceptors die.1,2 The disorder exhibits striking
genetic heterogeneity and can be inherited as an auto-
somal-dominant, autosomal-recessive, or X-linked trait.
More than 45 distinct RP-associated genes and/or loci
have been reported to date and include 23 genes associated
with nonsyndromic autosomal-recessive RP (RetNet, see
Web Resources). Notably, mutations in cilia-associated
genes account for at least 36% of genetically diagnosed
cases of RP.3 Within this ciliopathy category, mutations
can cause a broad spectrum of phenotypes ranging from
isolated RP to more complex syndromic ciliopathies (of
which RP is a component), such as Usher syndrome,
Bardet-Biedl syndrome, Meckel-Gruber syndrome, and
Senior-Loken syndrome.4,5
We investigated RP-affected families with evidence of
parental consanguinity. The study was approved by the
local research ethics committees atMoorfields Eye Hospital
and the Hadassah Hebrew Medical Center, and all investi-
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The Amerof the Declaration of Helsinki. Informed consent was ob-
tained from all participating individuals. One family of
Arab-Muslim origin (family MOL0807; Figure 1A) con-
sisted of three siblings affected by autosomal-recessive RP.
The clinical diagnosis of RP was made in their twenties, af-
ter complaints of night vision and visual-field impairment.
Individual IV-2 (Figure 1A), at the age of 33 years, had a
visual acuity of 0.2 in the right eye (RE) and 0.4 in the
left eye (LE), and his Goldmann visual fields were con-
stricted to 10–12 with the V4e target. When she was 36
years old, his older sister (IV-1; Figure 1A) had severely
impaired vision: she could detect hand motion in the RE
and had bare light perception in the LE. There were no
significant refractive errors. Mild posterior subcapsular
cataracts were present, and fundoscopy revealed optic-
disc pallor, mild-to-moderate bone-spicule-like pigmenta-
tion in the midperiphery, and attenuated retinal blood
vessels, all typical signs of RP. Interestingly, all three
siblings displayed a marked component of macular atro-
phy, including smaller and larger atrophic patches, as
well as epiretinal membranes with wrinkling of the retina
(Figures 2A–2D). Neither photopic nor scotopic electroret-
inogram (ERG) responses were detectable. Audiometric
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Figure 1. Identification of Homozygous
ARL2BP Variants in Two Unrelated
Consanguineous Families Affected by
Autosomal-Recessive RP
(A) Pedigrees analyzed in this study. On
the left is family MOL0807; homozygosity
mapping was performed on individuals IV-
1 and IV-2, and whole-exome sequencing
(WES) was performed with DNA from
individual IV-2. On the right is family
GC19277; homozygosity mapping and
WES were performed with DNA from
individual IV-3.
(B) A schematic of the genomic structure
of ARL2BP depicts the position of the mu-
tations identified in this study. A homozy-
gous splice-site mutation, c.101–1G>C
(IVS2–1G>C), was identified in individ-
uals IV-1, IV-2, and IV-3 from family
MOL0807 and is highlighted with a blue
star. A homozygous missense mutation,
c.134T>G (p.Met45Arg), was identified
in individual IV-3 from family GC19277
and is highlighted with a red star.
(C) Electropherograms of the mutations
identified in this study. On the left, traces
are shown for individual IV-2 (from
family MOL0807), homozygous for the
c.101–1G>C splice mutation, and a con-
trol individual. On the right, traces are
shown for individual IV-3 (from family
GC19277), homozygous for the c.134T>G
(p.Met45Arg) missense variant. Traces are
also shown for his unaffected sister (IV-2),
who is heterozygous for the same variant,
and an unrelated control sample. Both par-
ents (III-2 and III-3) were also found to be
heterozygous for the variant. All traces are
shown in the forward orientation.computed-tomography imaging revealed full thoracic and
abdominal situs inversus in individuals IV-1 and IV-2 but
normal situs composition (situs solitus) in individual IV-3.
DNA samples from individuals IV-1 and IV-2 (family
MOL0807) were analyzed with high-density genome-wide
SNP microarrays (Affymetirx SNP 6.0) according to the
manufacturer’s recommendations. Seven shared regions
of homozygosity greater than 5 Mb were identified and
were found to encompass multiple genes associated with
retinal disease (Table S1, available online). Subsequent
whole-exome sequencing (WES) using a Roche NimbleGen
V2 preparation kit and the HiSeq2000 sequencer (Illumina)
was performed with DNA from individual IV-2. The DNA-
nexus software package was used for aligning reads to the
human reference sequence (UCSC Genome Browser
hg19) and for calling and annotating sequence variants.
No variants in any known retinal-disease-associated genes,
including those present within large regions of homozy-
gosity, were identified (Table S1).
On the basis of the hypothesis that RP-associated muta-
tions are rare, calls with a minor allele frequency over 0.5%
in the 1000 Genomes database and the National Heart,
Lung, and Blood Institute (NHLBI) Exome Sequencing
Project Exome Variant Server (EVS) were filtered. Further-
more, on the basis of the consanguineous ancestry322 The American Journal of Human Genetics 93, 321–329, August 8observed, variants identified within regions of homozygos-
ity were examined initially. A homozygous splice-site
variant, c.1011G>C (IVS21G>C; Figure 1C), in ARL2BP
(RefSeq accession number NM_012106.3) was identified in
a large homozygous interval (Table S1). This variant alters
the invariant AG dinucleotide at the splice acceptor site
of intron 2 and segregates with disease in the family
(Figure 1C). This sequence change is absent from both
dbSNP and 1000 Genomes and is not present in DNA
from 100 ethnically matched Arab-Muslim control indi-
viduals. Furthermore, the variant is absent from 12,996
control haplotypes from the NHLBI EVS.
RT-PCR analysis of RNA extracted from blood samples of
the three affected siblings and their unaffected sibling,
who did not carry the mutation, revealed that the normal
spliced ARL2BP transcript was absent in all individuals ho-
mozygous for the c.1011G>C variant. Instead, multiple
PCR products were found to be present (Figure S1) and
were investigated by Sanger sequencing. The five amplified
products were all identified to represent abnormal splicing
events resulting in transcripts with a frameshift after 33 or
34 codons of the ARL2BP-coding sequence and the intro-
duction of premature termination codons (Figure S1). We
therefore predict that the identified splicing mutation
results in the lack of full-length ARL2BP in vivo., 2013
Figure 2. Retinal Imaging of Individuals with RP
(A–D) Fundus imaging of the RE and LE of individual IV-3 from family MOL0807 at the age of 31 years. Heidelberg MultiColor imaging
(A), infrared photos (B and D, left panels), and fundus autofluorescence images (C) show significant involvement of the macular area
with patches of atrophy surrounding the fovea, as well as smaller spots of retinal pigment epithelium (RPE) dropout throughout the pos-
terior pole. Optical coherence tomography (OCT) scans (B and D, right panels) show a relatively preserved photoreceptor layer in the
fovea, and marked thinning of this layer is evident in the parafoveal regions.
(E) Fundus autofluorescence imaging of the right and left retinas of individual IV-3 (family GC19277) at the age of 48 years. Irregular
peripheral autofluorescence consistent with RPE dysfunction or loss is evident. A parafoveal ring of increased density is noted; a similar
appearance has been previously described in individuals with RP and defects in photoreceptor-cilium-related genes.6
(F) Linear OCTscans of the left and right retinas of IV-3 in family GC19277. The hyperreflective line corresponding to the inner segment
ellipsoid is relatively preserved at the fovea but is absentmore peripherally, suggesting loss of photoreceptor outer segments. Outside the
fovea, observed thinning of the photoreceptor cell layer is consistent with extensive photoreceptor degeneration.
All scale bars represent 200 mm.In parallel, a 48-year-old white male (IV-3 in family
GC19277) of European descent, with evidence of parental
consanguinity (Figure 1A), and diagnosed with RP and pri-
mary ciliary dyskinesia (PCD [MIM 244400]; Table S2 and
Movie S1) was included in the study. He had respiratory
failure from an early age and required physiotherapy regu-
larly through the school years. He had recurrent otitis me-
dia, progressively affecting his hearing. In his twenties, he
noticed night-vision problems, which led to a diagnosis of
RP, and an ERG confirmed severe rod and cone dysfunc-
tion. There was progressive loss of peripheral vision and,
more recently, of central vision. There was no family his-
tory of any of these conditions. When he was 48 years
old, his visual acuities were 0.25 in the RE and 0.5 in the
LE and visual fields were constricted to 10. Fundus exam-
ination revealed widespread retinal degeneration with
only sparse bone-spicule pigmentation (Figures 2E and 2F).
On the basis of the proband’s consanguineous ancestry,
DNA from individual IV-3 (family GC19277) was analyzed
by homozygosity mapping, as described previously.The AmerThirteen chromosomal segments over 5Mbwere identified
and were found to encompass multiple retinal-disease-
associated genes (RetNet), in addition to two recently iden-
tified PCD-associated genes, DNAAF3 (MIM 614566)7 and
HYDIN (MIM 610812)8 on chromosomes 19 and 16,
respectively (Table S3). WES was performed with the Illu-
mina TruSeq Exome Enrichment Kit and the HiSeq 2000
sequencer (Illumina). Reads were aligned to the human
reference sequence (UCSC Genome Browser hg19) with
Novoalign (Novocraft) version 2.05. The ANNOVAR tool
(OpenBioinformatics) was used for annotating SNPs and
small indels. ExomeDepth9 was used for calling copy-
number variants.
A rare (1/12,331 control alleles [NHLBI EVS]) homozy-
gous splice-site variant was identified in HYDIN, a gene
recently associated with PCD8 (Figure S2). The variant
alters the invariant splice acceptor site of intron 24,
c.3786–1G>T (RefSeq NM_001270974.1). RT-PCR analysis
of RNA extracted from blood samples of individual IV-3
(family GC19277) and an unrelated control individualican Journal of Human Genetics 93, 321–329, August 8, 2013 323
revealed that the variant leads to aberrant pre-mRNA
splicing (Figure S3). To date, two loss-of-function HYDIN
variants have been reported in nine individuals affected
by PCD and hearing loss but with a normal situs composi-
tion (situs solitus) and absence of any retinal dystrophy,
congenital heart disease, or hydrocephalus.8 This is
thought to be because HYDIN-deficient cilia lack the C2b
projection of the central-pair apparatus, which is impor-
tant for 9þ2 motile cilia function, but not for 9þ0 primary
cilia.8 Electron microscopy of nasal epithelial cells of indi-
vidual IV-3 (family GC19277) confirmed the absence of the
C2b projection of the motile cilia (Figure S4). The PCD
phenotype and hearing loss observed in this subject are
therefore consistent with loss of HYDIN function and
resemble the phenotype of individuals already reported.
However, this did not explain his retinal degeneration.
We examined the WES data for possible causes of RP.
Overall, 22,778 exonic sequence alterations were identified
in individual IV-3’s (family GC19277 in Figure 1) exome
compared to the human reference sequence (UCSC
Genome Browser hg19). The average sequencing depth
on target was 613, and 87.9% of the targeted region was
covered with a minimum read depth of 10. No disease-
associated variants, including those present within large
regions of homozygosity, were identified in genes previ-
ously associated with RP or any other degenerative retinal
phenotypes (Table S3). Sanger sequencing excluded the
presence of causal variants in ORF15, the terminal exon
of the retina-enriched RPGR (MIM 312610) transcript.
Mutations in this X-linked gene are associated with RP
and, in some instances, additional ciliopathy-related fea-
tures including sinorespiratory infections and deafness.10
WES data were filtered as described for family MOL0807.
In total, six rare nonsynonymous variants were identified
in the homozygous regions. A homozygousmissense variant
(c.134T>G [p.Met45Arg]) present in ARL2BP within the
largest region of homozygosity on chromosome 16 was
considered most likely to be pathogenic (Figure 1C and
Table S3). The variant was found to segregate with disease in
the family (Figure 1C). This sequence change is absent from
both dbSNP and 1000 Genomes and is not present in DNA
from 192 ethnically matched control individuals (Human
RandomControlDNAPanels). Furthermore, thevariant isab-
sent from 12,996 control haplotypes (NHLBI EVS). The
Met45 residue is located in an evolutionarily conserved re-
gion of the protein (Figure S5), and bioinformatics programs
SIFT, PolyPhen-2, and Blosum62 support the likely pathoge-
nicity of the identified ARL2BPmissense variant (Table S4).
ARL2BP represents an attractive candidate for cilia-
related disorders, such as RP, because ARF-like GTPases,
their effectors, and GTPase-activating protein (GAP) play
critical roles in cilia formation and signaling.11,12 ARL3-
knockout mice have a phenotype consistent with primary
cilia dysfunction,13 and alterations in the ARL3 GAP,
encoded by RP2, cause X-linked RP (MIM 300757).14,15
ARL3 shares a high degree of structural, and possibly func-
tional, conservation with ARL2, and both proteins share a324 The American Journal of Human Genetics 93, 321–329, August 8highly overlapping set of effector proteins, such as
ARL2BP.16 However, neither ARL2 nor ARL2BP has been
previously implicated in human disease.
The identification of rare homozygous ARL2BP variants
in four RP-affected individuals from two unrelated families
led us to assess whether mutations in ARL2BP are a com-
mon cause of adult-onset autosomal-recessive retinal
degeneration. Bidirectional Sanger sequencing of ARL2BP
was performed for 298 unrelated individuals diagnosed
with autosomal-recessive retinal degeneration, but no
disease-associated variants were identified. Additionally,
no potential disease-associated variants were identified in
WES data generated from 60 additional individuals diag-
nosed with retinal degeneration.
ARL2BP has been previously identified as a centrosome-
associated protein in a variety of mammalian cell lines;
however, no previous studies have described retinal locali-
zation or association with a human phenotype.17 The
retinal localization of ARL2BP was determined in cryofixed
C57B16 mouse eye sections18,19 stained with ARL2BP
antibodies. ARL2BPwasdetected in the regionof thephoto-
receptor connecting cilium (Figures 3A and 3B). Higher
magnifications of photoreceptor connecting cilia triple
stained for ARL2BP, the cilia, basal body, and centriole
marker centrin-3 and the periciliary marker PCM-1 verified
the localization of ARL2BP to the basal body, adjacent
centriole, andciliary rootlet (Figure3C). Thiswas confirmed
with a second antibody to ARL2BP (Figure S6). Moreover,
localization at the distal connecting cilia was corroborated
by immunofluorescence (Figure 3C) and immunoelectron
microscopy (Figure 3D). For immunoelectron microscopy,
we applied a previously described pre-embedding labeling
protocol.20,21 Transmission electron microscopy further
revealed ARL2BP localization in the periciliary extension
of the inner segment and confirmed its localization at the
basal body, at the adjacent centriole, and in the ciliary root-
let (Figures 3C and 3D).
The basal body complex and the periciliary extension of
the inner segment are important for targeting and regu-
lating protein entry into the primary cilium, thus acting
as docking sites for pericentriolar transport vesicles and
intraflagellar transport (IFT) particles.20–23 Therefore, it is
possible that ARL2BP functions in the targeting, docking,
or loading of proteins and/or vesicles in the periciliary
region for cilia-associated traffic. The presence of ARL2BP
in distal connecting cilia, where new outer-segment disks
are formed, affirms the close relation between ARL2BP
and IFT molecules, which show analogous spatial distribu-
tion in ciliary subcompartments,20 and indicates a poten-
tial role in disk neogenesis.
Localization of ARL2BP in the basal body was confirmed
in mouse fibroblast cells (NIH 3T3) and human retina
pigment epithelial cells (ARPE19) (Figures 4A and 4B) by
immunocytochemistry (ICC) as described previously.19,24
After treatment with ARL2BP siRNA, cytoplasmic and basal
body staining of ARL2BP was reduced to undetectable
levels in over 70% of cells, and immunoblotting confirmed, 2013
Figure 3. ARL2BP Is a Basal Body Protein
(A) Mouse retina cryosections were stained for ARL2BP (green, 1:1,000 in-house antibody RK16), counterstained for the ciliary marker
centrin-3 (Cen3, red, 1:100 antibody20), and stained with DAPI (blue) for the outer nuclear layer (ONL) and inner nuclear layer
(INL). ARL2BP colocalized with Cen3 in the ciliary region of photoreceptor cells (arrowhead).
(B) A close-up view of the junction of the photoreceptor inner segment (IS), connecting cilia (CC), and outer segment (OS) shows
ARL2BP (green) overlap with Cen3 (red).
(C) High-resolution immunofluorescence of the ciliary region in photoreceptors of the mouse retina. Triple labeling of ARL2BP (green),
Cen3 (white), and pericentrin (PCM-1, red, 1:400 Abcam) revealed localization of ARL2BP in the distal CC (arrowhead), basal body (BB),
ciliary-associated centriole (Ce), and ciliary rootlet (Cr) of photoreceptor cells. On the bottom right is a color-coded schematic of ARL2BP
localization relative to that of Cen3 and PCM-1.
(D) Immunoelectron microscopy of mouse photoreceptors shows ARL2BP ultrastructural localization at the junction of the OS and IS;
labeling of the BB, Ce, and distal CC is marked with arrowheads. In addition, some labeling was observed in the Cr projecting into the IS.
Other abbreviations are as follows: OPL, outer plexiform layer; IPL, inner plexiform layer; and GCL, ganglion cell layer. Scale bars repre-
sent 25 mm (A), 10 mm (B), 1 mm (C), and 0.2 mm (D).that the protein level was reduced by approximately 90%
(Figure 4B and Figure S7). Interestingly, staining of ARL2BP
at the basal body was also lost in over 70% of cells trans-
fected with ARL2 siRNA, even though the overall levels of
ARL2BP were not affected (Figure 4B and Figure S7). In
contrast, siRNAs targeting ARL3 or the ARL3 GAP RP2
had no effect on ARL2BP localization or protein levelsThe Amer(Figures S7C and S7D). The specificity of one ARL2BP anti-
body has been previously reported16 and was confirmed for
both antibodies by ARL2BP siRNA with ICC and immuno-
blotting (Figure 4 and Figures S6 and S7). The efficiency of
siRNAs against ARL2BP, ARL2, and ARL3 was confirmed by
immunoblotting or RT-PCR (Figure S7), and the specificity
of the siRNA against RP2 has been described previously.19ican Journal of Human Genetics 93, 321–329, August 8, 2013 325
Figure 4. ALR2BP Cilia Targeting Is Dependent on ARL2 and Is Disrupted by the p.Met45Arg Amino Acid Substitution
(A) ARL2BP localized to the base of the cilium in mouse fibroblast cells (NIH 3T3). Cilia (green) were stained with acetylated a-tubulin
antibody (acetyl a-tubulin, 1:1,000, Sigma Aldrich) and for ARL2BP (red) (1:500 antibody, Protein Tech Group).
(B) In human RPE cells (ARPE19), ARL2BP (red, 1:1,000 in-house antibody16) colocalized with the basal body marker PCM-1 (green,
1:1,000). ARL2BP localization at the basal body was abolished by ARL2BP or ARL2 siRNA, but not by control siRNA. Basal body locali-
zation is highlighted by an arrow. Inserts show higher magnification of ARL2BP basal body localization. siRNAs for ARL2, ARL3, RP2, or
ARL2BP and a nontargeting control siRNA were obtained from Dharmacon.
(C) Reciprocal coimmunoprecipitation (co-IP) of vsv-tagged ARL2 with wild-type (WT) or p.Met45Arg (p.M45R) Myc-tagged ARL2BP
immunoblotted for ARL2 and ARL2BP, as indicated. Compared to that of WT ARL2BP, the binding of p.Met45Arg ARL2BP to ARL2
was reduced by 90%. Immunoblots from three independent experiments were analyzed with ImageJ software (National Institutes of
Health). Human Myc-tagged ARL2BP in pcDNA4/TO/Myc-HIS A was from Abgent, and bovine ARL2 in pcDNA4/TO/vsv was a kind
gift from Jane Evans (UCL Institute of Ophthalmology). For co-IPs, equal amounts of ARL2BP and ARL2 were transfected into SK-N-
SH cells. The ARL2BP p.Met45Arg variant was introduced by site-directed mutagenesis (QuickChange, QIAGEN). The goat Arl2 antibody
was purchased from Abcam (1:200) and used for immunoprecipitation (IP), and the vsv antibody (1:50), a kind gift from Karl Matter, was
used for immunoblotting. The Myc antibody (1:1,000, Sigma Aldrich) was used for IPs and immunoblotting of Myc-tagged ARL2BP.
n ¼ 3 co-IPs for quantification of ARL2 binding to ARL2BP. Values are means5 SEM; ***p% 0.001.
(D) ARL2BP localizes to the basal body region in human nasal epithelial cells, but not in cells derived from individual IV-3 from family
GC19277 (lower panel). Cilia (green) were stained for acetylated a-tubulin (1:1,000 antibody, Sigma Aldrich) and for ARL2BP (red, 1:100
antibody16).
Scale bars represent 10 mm.These findings suggest that the interaction between
ARL2BP and ARL2 is important for recruitment or
anchoring of ARL2BP at the basal body. ARL2BP and
ARL2 siRNAs appeared to have no major adverse effect
on ARPE19 cell morphology, survival, or division (data
not shown). To determine the effect that loss of ARL2BP
at the basal body has on cilia morphology, we examined
cilia incidence and length in ARPE19 cells by staining for
the cilia membrane protein ARL13B after treatment with
ARL2BP, ARL2, and control siRNA. The incidence of cells
displaying cilia and normal cilia morphology was unaf-
fected by treatment with control siRNA (Figure S8). How-
ever, in cells treated with ARL2BP or ARL2 siRNA, there
was a significant reduction in cilia length (Figure S8).
To investigate the effect of the p.Met45Arg amino acid
substitution (IV-3 in family GC19277; Figure 1) on ARL2BP,
we overexpressed wild-type and p.Met45Arg ARL2BP in326 The American Journal of Human Genetics 93, 321–329, August 8human SK-N-SH neuroblastoma cells. The substitution did
not affect expression levels of ARL2BP (Figure 4C), suggest-
ingnomajor effect onprotein stability. Therefore, we tested
the hypothesis that the amino acid substitution affects the
interaction with ARL2 by using coimmunoprecipitation, as
previously described.24 The interaction between wild-type
Myc-tagged ARL2BP and vsv-tagged ARL2 (Figure 4C) was
confirmed, but the level of binding between vsv-tagged
ARL2 and p.Met45Arg Myc-tagged ARL2BP was 90% lower
than the level of binding between vsv-tagged ARL2 and
wild-type Myc-tagged ARL2BP (Figure 4C).
To determine the significance of this finding in vivo, we
investigated ARL2BP expression in nasal epithelial cells from
individual IV-3 (familyGC19277) and healthy controls. Nasal
epithelial cells from nasal brush biopsies were sampled from
individual IV-3 and three control individuals without ciliary
disease with the use of a modified cytology brush, and, 2013
immunofluorescence staining of the cells was performed as
previously described.25,26 In control epithelial cells, ARL2BP
was enriched at the basal body region of the cell beneath the
motile cilia, stained for acetylated a-tubulin (Figure 4D) or
g-tubulin (Figure S9). However, in individual IV-3’s (family
GC19277) epithelial cells, which contained only the
p.Met45Arg amino acid substitution, ARL2BP was distributed
diffusely in the cytoplasm and was not enriched at the basal
bodies (Figure 4Dand Figure S9). This supports the hypothesis
that the binding of ARL2BP to ARL2 is critical for localization
of ARL2BP to the basal body. We hypothesize that because
the level of binding between ARL2 and p.Met45Arg ARL2BP
is lower than the level of binding between ARL2 and wild-
type ARL2BP, ARL2 is not able to sufficiently recruit or anchor
the altered ARL2BP to the base of the cilium.
ARL2 shares a high degree of structural, and possibly func-
tional, conservation with ARL3, given that ARL2 and ARL3
have common binding partners, including UNC119,27,28
a subunit of phosphodiesterase (PDE6D),29,30 and
ARL2BP.16PDE6DandUNC119share extensive sequenceho-
mologyandcooperatewithARL2and/orARL3to regulate the
membrane association of posttranslationally modified acyl-
ated and prenylated proteins, such as the a-subunit of trans-
ducin, NPHP4, and Rheb.31–33 RP2 localizes to the ciliary
apparatus at the base of the photoreceptor cilium and, along
withARL3, facilitates the traffic andmembrane associationof
NPHP4, transducin, and potentially other cilia-associated
proteins.24,32,34–36 Therefore, the cooperation between
ARL3 and its regulatory proteins (such as RP2) and effector
proteins (such as UNC119) is important for the correct func-
tion of ciliated cells and photoreceptors in particular. Howev-
er, little is known about the role of ARL2 in cilia function. For
example, ARL2 binds to UNC119 but does not release
cargo from UNC119,31 suggesting that despite their
similarity, ARL2 and ARL3 have different functions in the
retina. In addition, ARL2BP binds the same site in ARL2
asdo theeffectorsUNC119andPDE6D37andwouldcompete
for binding to the activated GTPase. Importantly, we have
shown that the targeting of ARL2BP to cilia is dependent on
ARL2,notARL3.Therefore, the role ofARL2BP incilia is likely
to be distinct from that of the ARL3-RP2-UNC119 complex
and ARL2-PDE6D and ARL3-PDE6D. In this study, we
describeARL2BPmutations associated with autosomal-reces-
sive RP, demonstrating that ARL2BP plays an essential role in
the retina, and show that this role is mediated in part by the
ARL2BP-ARL2 interaction but does not involve ARL3.Supplemental Data
Supplemental Data include nine figures, four tables, and one
movie and can be found with this article online at http://www.
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